Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
SX682
Nasopharyngeal Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(43)
Tazemetostat Hydrobromide
Metastatic Melanoma
National Cancer Institute (NCI)
P1/2
CC
(43)
Veliparib
Lung Adenocarcinoma
National Cancer Institute (NCI)
P1/2
CC
(43)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
National Cancer Institute (NCI)
P2
CC
(42)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)
P2
CC
(42)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)
P2
CC
(42)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer
Plasmablastic Lymphoma
National Cancer Institute (NCI)
P2
CC
(42)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer
T-Cell/Histiocyte Rich Large B Cell Lymphoma
National Cancer Institute (NCI)
P2
CC
(42)
Selumetinib
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P2
CC
(42)
Anti-Icos Monoclonal Antibody Medi-570
Follicular Lymphoma
National Cancer Institute (NCI)
P1
CC
(42)
Atezolizumab
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)
P1
CC
(42)
Autologous Ccr4 Car T Cells
Hepatosplenic T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(42)
Belinostat
B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(42)
Cabozantinib
Kaposi'S Sarcoma
National Cancer Institute (NCI)
P1
CC
(42)
Cabozantinib
Psoriatic Arthritis
National Cancer Institute (NCI)
P1
CC
(42)
Cabozantinib
Systemic Lupus Erythematosus
National Cancer Institute (NCI)
P1
CC
(42)
Cedazuridine
B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(42)
Elimusertib
Pancreatic Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(42)
Kras Tcr-Transduced Pbl
Ovarian Cancer
National Cancer Institute (NCI)
P1
CC
(42)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Ureter Cancer
National Cancer Institute (NCI)
P1
CC
(42)
Sinecatechins
Cirrhosis Of Liver
National Cancer Institute (NCI)
P1
CC
(42)
Tnhyp217 Car T Cells
Mesothelioma
National Cancer Institute (NCI)
P1
CC
(42)
Tnhyp217 Car T Cells
Pancreatic Neoplasm
National Cancer Institute (NCI)
P1
CC
(42)
Veliparib
Kidney Failure
National Cancer Institute (NCI)
P1
CC
(42)
Enitociclib
Hematopoietic And Lymphoid System Neoplasm
National Cancer Institute (NCI)
P1/2
CC
(42)
Showing 3076 to 3100 of 3,272 assets
Previous
Page 124 of 131
Next